Bond SE - Search Results

1

Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.

Zheng X, Salgia SR, Thompson WB, Dillingham EO, Bond SE, Feng Z, Prasad KR, Gollamudi R. Zheng X, et al. Among authors: bond se. J Med Chem. 1995 Jan 6;38(1):180-8. doi: 10.1021/jm00001a023. J Med Chem. 1995. PMID: 7837229

2

In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.

Lyman BA, Bond SE, Dillingham EO, Lawrence WH, Gollamudi R. Lyman BA, et al. Among authors: bond se. Res Commun Chem Pathol Pharmacol. 1992 Dec;78(3):279-88. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1475529

3

Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines.

Feng Z, Gollamudi R, Dillingham EO, Bond SE, Lyman BA, Purcell WP, Hill RJ, Korfmacher WA. Feng Z, et al. Among authors: bond se. J Med Chem. 1992 Aug 7;35(16):2952-8. doi: 10.1021/jm00094a004. J Med Chem. 1992. PMID: 1501222

4

Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agent.

Gollamudi R, Dillingham EO, Bond SE, Lyman BA. Gollamudi R, et al. Among authors: bond se. Biochem Biophys Res Commun. 1991 Jun 14;177(2):888-93. doi: 10.1016/0006-291x(91)91873-b. Biochem Biophys Res Commun. 1991. PMID: 2049109

5

The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability.

Dillingham EO, Lasslo A, Gollamudi R, Bond SE, Carter-Burks G. Dillingham EO, et al. Among authors: bond se. Res Commun Chem Pathol Pharmacol. 1990 Feb;67(2):179-99. Res Commun Chem Pathol Pharmacol. 1990. PMID: 2333408

6

Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregation.

Petrusewicz J, Lasslo A, Carter-Burks G, Gollamudi R, Dillingham EO, Bond SE. Petrusewicz J, et al. Among authors: bond se. Biochim Biophys Acta. 1989 Aug 7;983(2):161-6. doi: 10.1016/0005-2736(89)90229-0. Biochim Biophys Acta. 1989. PMID: 2758055

7

Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4.

Dillingham EO, Lasslo A, Carter-Burks G, Bond SE, Gollamudi R. Dillingham EO, et al. Among authors: bond se. Biochim Biophys Acta. 1989 Feb 24;990(2):128-32. doi: 10.1016/s0304-4165(89)80023-6. Biochim Biophys Acta. 1989. PMID: 2917173

8

Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.

Herron D, Dillingham EO, Lyman BA, Zheng X, Bond SE, Salgia SR, Gollamudi R. Herron D, et al. Among authors: bond se. Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):309-18. doi: 10.1016/0952-3278(95)90032-2. Prostaglandins Leukot Essent Fatty Acids. 1995. PMID: 7630919

9

Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.

Gollamudi R, Dillingham EO, Bond SE. Gollamudi R, et al. Among authors: bond se. Blood Coagul Fibrinolysis. 1994 Jun;5(3):375-83. Blood Coagul Fibrinolysis. 1994. PMID: 8075309

10

Enantioselective antiplatelet actions of nipecotamides.

Gollamudi R, Feng Z, Dillingham EO, Bond SE, Han G, Salgia S. Gollamudi R, et al. Among authors: bond se. Thromb Res. 1993 Feb 15;69(4):361-7. doi: 10.1016/0049-3848(93)90035-m. Thromb Res. 1993. PMID: 8470057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters